Loading...

Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 116.28 USD +5.34% Market Closed
Updated: Dec 1, 2022

Intrinsic Value

The intrinsic value of one DXCM stock under the Base Case scenario is 43.94 USD. Compared to the current market price of 116.28 USD, Dexcom Inc is Overvalued by 62%.

The Intrinsic Value is calculated as the average of the two valuation methods:

DXCM Intrinsic Value
Base Case
43.94 USD
Overvaluation 62%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

DXCM Profitability Score
Profitability Due Diligence

Dexcom Inc's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

Positive ROE
Positive ROIC
Positive Operating Income
Positive Net Income
68/100
Profitability
Score

Dexcom Inc's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

DXCM Solvency Score
Solvency Due Diligence

Dexcom Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Average D/E
Negative Net Debt
Long-Term Liabilities
Short-Term Liabilities
80/100
Solvency
Score

Dexcom Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
66%
Gross Margin
10%
Operating Margin
8%
Net Margin
9%
FCF Margin
12%
ROE
12%
ROIC
Other

DXCM Capital Structure
Dexcom Inc

Market Capitalization 44.9B USD
Total Debt 2B USD
Minority Interest 0 USD
Preferred Equity 0 USD
Cash and Equivalents 698M USD
Short-Term Investments 1.7B USD
Enterprise Value 44.6B USD

Wall St
Price Targets

DXCM Price Targets Summary
Dexcom Inc

Wall Street analysts forecast DXCM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXCM is 121.59 USD .

Lowest
Price Target
Not Available
Average
Price Target
121.59 USD
5% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

DXCM Competitors
Dexcom Inc

DXCM Suppliers & Customers
Dexcom Inc

Dexcom Inc has 8 key suppliers from 3 countries and 4 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Health Care industry.

Dexcom Inc has 8 key customers from 1 countries and 2 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Health Care industry.

Ownership

DXCM Shareholders
Major Shareholders

Insiders don't own a significant part of the company.

Top 25 shareholders own 45.46% of the company. Insiders own 0.6%. The biggest insider is Sayer Kevin R (Chairman, CEO & President), who owns 0.1014% of Dexcom Inc.

Insiders
0.6%
Institutions
71.96%
Other
27.44%
Insiders
0.6%
Sayer Kevin R
Chairman, CEO & President
Ownership
0.1014%
Market Value
45.5M USD
Shares
391 532
Leach Jacob Steven
EVP Chief Technology Officer
Ownership
0.0774%
Market Value
34.8M USD
Shares
298 984
Gregg Terrance H
Former Executive Chairman
Ownership
0.0572%
Market Value
25.7M USD
Shares
221 128
Abbey Donald
EVP Quality Regulatory Affairs
Ownership
0.052%
Market Value
23.4M USD
Shares
200 916
Ace Heather S
SVP Human Resources
Ownership
0.04%
Market Value
17.9M USD
Shares
154 336
Pacelli Steven Robert
EVP Managing Director Dexcom V
Ownership
0.0356%
Market Value
16M USD
Shares
137 700
Moy Jeffrey
EVP Operations
Ownership
0.0204%
Market Value
9.2M USD
Shares
78 736
Blackford Quentin S.
Chief Operating Officer
Ownership
0.02%
Market Value
9M USD
Shares
77 120
Stern Sadie
EVP Chief Human Resources Offi
Ownership
0.0177%
Market Value
8M USD
Shares
68 384
Sylvain Jereme M
EVP Chief Financial Officer
Ownership
0.0174%
Market Value
7.8M USD
Shares
67 237
Murphy Patrick Michael
EVP, Chief Legal Officer
Ownership
0.0168%
Market Value
7.6M USD
Shares
65 064
Flynn Paul R
EVP Global Revenue
Ownership
0.0168%
Market Value
7.5M USD
Shares
64 732
Balo Andrew K
EVP, Global Medical Affairs
Ownership
0.0162%
Market Value
7.3M USD
Shares
62 460
Regan Barry J.
EVP Operations
Ownership
0.0159%
Market Value
7.2M USD
Shares
61 599
Shrishrimal Sumi
SVP Chief Risk Officer
Ownership
0.0143%
Market Value
6.4M USD
Shares
55 156
Patterson Chad
EVP Global Marketing
Ownership
0.0142%
Market Value
6.4M USD
Shares
54 700
Selvaraj Shelly Ramasamy
SVP Chief Information Officer
Ownership
0.0129%
Market Value
5.8M USD
Shares
49 942
Brown Michael Jon
EVP Chief Legal Officer
Ownership
0.0125%
Market Value
5.6M USD
Shares
48 152
Naganathan Girish
EVP Chief Technology Officer
Ownership
0.0081%
Market Value
3.7M USD
Shares
31 449
Doubleday Richard
EVP Chief Commercial Officer
Ownership
0.007%
Market Value
3.1M USD
Shares
26 992
Dolan Matthew Vincent
SVP Corporate Strategy-Develop
Ownership
0.0069%
Market Value
3.1M USD
Shares
26 536
Heller Bridgette P
Director
Ownership
0.0055%
Market Value
2.5M USD
Shares
21 420
Malady Kyle
Director
Ownership
0.0033%
Market Value
1.5M USD
Shares
12 644
Dahut Karen M
Director
Ownership
0.0018%
Market Value
819k USD
Shares
7 040
Foletta Mark G
Director
Ownership
0.0012%
Market Value
522k USD
Shares
4 488
Augustinos Nicholas
Director
Ownership
0.001%
Market Value
462k USD
Shares
3 976
Kahn Barbara
Director
Ownership
0.001%
Market Value
462k USD
Shares
3 976
Topol Eric
Director
Ownership
0.001%
Market Value
460k USD
Shares
3 952
Collins Richard Alexander
Director
Ownership
0.001%
Market Value
459k USD
Shares
3 948
Altman Steven R
Director
Ownership
0.001%
Market Value
455k USD
Shares
3 916
Skyler Jay S
Director
Ownership
0.001%
Market Value
451k USD
Shares
3 876
Institutions
71.96%
Back

DXCM Insider Trading
Buy and sell transactions by insiders

Dexcom Inc insiders have only sold shares in the past 12 months.

During the last 12 months Dexcom Inc insiders have not bought any shares, and sold 22.3M USD worth of shares. The last transaction was made on Dec 1, 2022 by Sylvain Jereme M (EVP Chief Financial Officer), who sold 270k USD worth of DXCM shares.

Sold
0-3
months
270k USD
1
3-6
months
964k USD
3
6-9
months
20.7M USD
7
9-12
months
64.6M USD
6
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
270k USD
N/A
-270.3k
6 Months
691k USD
N/A
-691.5k
9 Months
5.9M USD
N/A
-5.9M
12 Months
22M USD
N/A
-22M
Purchases
42
Sales
964